Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Synopsys Stock (SNPS) Opinions on Q1 Earnings and Analyst Downgrade

None

Earnings Strength: Social media erupted following Synopsys' robust Q1 fiscal 2026 results, which beat revenue and EPS forecasts amid surging AI-driven design demand. Conversations praised the smooth Ansys acquisition integration and a hefty $11.3 billion backlog signaling sustained momentum. Management's raised full-year EPS outlook fueled optimism about long-term growth.

Downgrade Concerns: Buzz soured after Morgan Stanley downgraded the stock to equal-weight, pointing to decelerating electronic design automation growth. Shares tumbled, sparking debates on whether high valuations overlook transitional challenges in IP sales. Critics highlighted year-to-date underperformance versus broader tech indices despite solid fundamentals.

Buyback Signal: Fresh discussion emerged around Synopsys' $250 million accelerated share repurchase agreement, interpreted as a strong endorsement from insiders. This move replenishes the buyback program post-earnings, countering some downgrade pessimism. Traders weighed it against China-related headwinds, viewing it as a stabilizing factor.

Note: This discussion summary was generated from an AI condensation of post data.

Synopsys Insider Trading Activity

SNPS Insider Trades

Synopsys insiders have traded $SNPS stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $SNPS stock by insiders over the last 6 months:

  • SUDHINDRA KANKANWADI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 15,873 shares for an estimated $7,837,408.
  • SASSINE GHAZI (PRESIDENT AND CEO) sold 11,366 shares for an estimated $6,694,725
  • SHELAGH GLASER (CFO) has made 0 purchases and 4 sales selling 7,312 shares for an estimated $3,913,745.
  • JANET LEE (GC & Corporate Secretary) has made 0 purchases and 2 sales selling 500 shares for an estimated $260,000.
  • ROBERT G PAINTER purchased 350 shares for an estimated $148,903

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Synopsys Revenue

SNPS Quarterly Revenue

Synopsys had revenues of $2.4B in Q1 2026. This is an increase of 65.52% from the same period in the prior year.

You can track SNPS financials on Quiver Quantitative's SNPS stock page.

Synopsys Congressional Stock Trading

Members of Congress have traded $SNPS stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $SNPS stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Synopsys Hedge Fund Activity

We have seen 568 institutional investors add shares of Synopsys stock to their portfolio, and 949 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Synopsys Government Contracts

We have seen $342,606 of award payments to $SNPS over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Synopsys Analyst Ratings

Wall Street analysts have issued reports on $SNPS in the last several months. We have seen 10 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

  • Rosenblatt issued a "Buy" rating on 12/11/2025
  • B of A Securities issued a "Buy" rating on 12/11/2025
  • Citigroup issued a "Buy" rating on 11/24/2025
  • Exane BNP Paribas issued a "Underperform" rating on 10/02/2025
  • Morgan Stanley issued a "Overweight" rating on 09/11/2025
  • Mizuho issued a "Outperform" rating on 09/11/2025
  • JP Morgan issued a "Overweight" rating on 09/10/2025

To track analyst ratings and price targets for Synopsys, check out Quiver Quantitative's $SNPS forecast page.

Synopsys Price Targets

Multiple analysts have issued price targets for $SNPS recently. We have seen 14 analysts offer price targets for $SNPS in the last 6 months, with a median target of $555.0.

Here are some recent targets:

  • Lee Simpson from Morgan Stanley set a target price of $480.0 on 02/27/2026
  • Blair Abernethy from Rosenblatt set a target price of $530.0 on 02/26/2026
  • Clarke Jeffries from Piper Sandler set a target price of $430.0 on 02/26/2026
  • Joe Quatrochi from Wells Fargo set a target price of $450.0 on 02/26/2026
  • Jason Celino from Keybanc set a target price of $600.0 on 12/11/2025
  • Vivek Arya from B of A Securities set a target price of $560.0 on 12/11/2025
  • Charles Shi from Needham set a target price of $580.0 on 12/11/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles